eurotrophic factor study
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0001584
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 320
First episode: They have to have symptoms requiring antipsychotic treatment with illness duration of no longer than 3 years and a lifetime history of previous antipsychotic exposure of = 2 consecutive weeks.
Recent and Chronic: Within five years after the onset patients with recent onset and over 5 years
Patients will be excluded for any of the following reasons: i) meeting DSM-IV criteria for another axis I diagnosis, including substance abuse or dependence; ii) having a serious or unstable medical illness in which pharmacotherapy would prove a significant clinical risk; and iii) pregnant or lactating women.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive and negative Syndrome Scale (PANSS, Kay et al 1987);Scale for the Assessment of Negative Symptoms (SANS, Andreasen 1984);Clinical Global Impressions-Schizophrenia Scale (CGI-SCH)
- Secondary Outcome Measures
Name Time Method Social and Occupational Functioning Assessment Scale (SOFAS, Patterson and Lee 1995)